Corbus Pharmaceuticals Holdings (CRBP) Other Accumulated Expenses (2014 - 2021)

Corbus Pharmaceuticals Holdings' Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $1.7 million for Q4 2021.

• On a quarterly basis, Other Accumulated Expenses rose 19.02% year-over-year to $1.7 million in Q4 2021; TTM through Dec 2021 was $1.7 million, a 19.02% increase from a year earlier, with the FY2021 full-year figure at $1.7 million, up 19.02% from the prior year.
• Other Accumulated Expenses advanced to $1.7 million in Q4 2021 per CRBP's latest filing, from $1.4 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $1.7 million in Q4 2021 and bottomed at $110446.0 in Q2 2017.
• The 5-year median for Other Accumulated Expenses is $953206.0 (2019), against an average of $921957.2.
• Across the five-year window, Other Accumulated Expenses soared 440.34% in 2019 and slipped 16.06% in 2021, its largest moves.
• Year by year, Other Accumulated Expenses stood at $146609.0 in 2017, then surged by 214.17% to $460596.0 in 2018, then jumped by 108.19% to $958928.0 in 2019, then jumped by 52.35% to $1.5 million in 2020, then advanced by 19.02% to $1.7 million in 2021.
• Per Business Quant, the three latest CRBP Other Accumulated Expenses figures stand at $1.7 million (Q4 2021), $1.4 million (Q3 2021), and $1.5 million (Q2 2021).